UBS AM Sells 867,648 Shares of Merck & Co., Inc.

UBS AM, a distinct business unit of UBS Asset Management Americas LLC, has reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 4.3% during the second quarter. The firm owned approximately 19,547,171 shares of the company's stock after selling 867,648 shares during the period.

The sale was disclosed to the Securities and Exchange Commission in a recent filing. UBS AM's holdings in Merck & Co., Inc. were valued at $2,511,811,000 at the end of the most recent reporting period, which represents approximately 0.79% of the company's outstanding shares.

Merck & Co., Inc.'s stock price opened at $148.30 on Friday. The company has a market capitalization of $365.88 billion and a debt-to-equity ratio of 1.22.